Full video transcriptClick to expand
Auto-generated transcript of @sharonvanwyk3's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00What I eat in a day on a zig pick that has resulted in my 22 kilogram weight loss so far.
- 0:07But before you jump into the comments to ask for my meal plan, let me start off by saying there isn't a meal plan.
- 0:13I'm just following the basic principles of a balanced diet.
- 0:16No food exclusions aside from a dramatic reduction in my alcohol consumption.
- 0:22So breakfast is two tablespoons of shear seeds which are allowed to soak in some Greek style yogurt with my daily collagen,
- 0:29low carb, nacrolola, a blob of maple syrup and some blueberries.
- 0:39Lunch was some Asian slaw with some shredded rotisserie chicken, a teaspoon of seeds and a drizzle of sriracha dressing.
- 0:46And supper was chicken in a spicy yogurt based marinade on the bry with a green salad and a baked potato.
- 1:00I generally don't snack on a zim pick as I find that I've actually had enough to eat and I'm not hungry or feel like anything else to eat.
- 1:09Let me know in the comments if you found this helpful.
What a 22kg Ozempic weight loss story gets right and wrong
Quick answer
Sharon describes eating a high-protein, vegetable-forward diet with reduced alcohol while on semaglutide (Ozempic), crediting the combination with a 22kg weight loss. Her reported appetite suppression and absence of snacking are consistent with semaglutide's documented effects on gastric emptying and hypothalamic satiety signaling. The dietary pattern she follows broadly aligns with clinical recommendations for optimizing body composition outcomes during GLP-1 receptor agonist therapy, though protein intake targets and resistance training are not addressed in her account.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Compounded Semaglutide access requires the right clinical path
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 9 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For What a 22kg Ozempic weight loss story gets right and wrong, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Primary STEP 1 trial source for semaglutide weight-management efficacy and adverse-event context.
PubMed
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance
Used for maintenance, discontinuation, and weight-regain discussions after semaglutide response.
PubMed
Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference
A broad meta-analysis anchor for GLP-1 weight-loss effect and class-level comparisons.
PubMed
Discontinuing glucagon-like peptide-1 receptor agonists and body habitus
Used for pages discussing stopping therapy, weight regain, and long-term planning.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Compounded Semaglutide is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Claim path
Keep researching this semaglutide video claims cluster
Best for searchers comparing social semaglutide claims with GLP-1 eligibility, outcomes, and safety context.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "What a 22kg Ozempic weight loss story gets right and wrong" from Sharon van Wyk 🇿🇦. We read the clip as a GLP-1 social video fact-checks claim about Compounded Semaglutide, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Sharon describes eating a high-protein, vegetable-forward diet with reduced alcohol while on semaglutide (Ozempic), crediting the combination with a 22kg weight loss.
The reason this review is not generic is the source wording and the canonical claim label "glp1 i thought i d do a more summary edition of what i eat in a d." In this clip, the useful excerpt is: "What I eat in a day on a zig pick that has resulted in my 22 kilogram weight loss so far." That wording changes the review because it points to Compounded Semaglutide safety, access, evidence, and fit, not a one-size-fits-all protocol.
The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. Compounded Semaglutide still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
Sharon describes eating a high-protein, vegetable-forward diet with reduced alcohol while on semaglutide (Ozempic), crediting the combination with a 22kg weight loss.
FormBlends verdict
Compounded Semaglutide safety, access, evidence, and fit
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with the Compounded Semaglutide guide, safety notes, access rules, and a licensed-provider review.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Sharon describes eating a high-protein, vegetable-forward diet with reduced alcohol while on semaglutide (Ozempic), crediting the combination with a 22kg weight loss. Her reported appetite suppression and absence of snacking are consistent with semaglutide's documented effects on gastric emptying and hypothalamic satiety signaling. The dietary pattern she follows broadly aligns with clinical recommendations for optimizing body composition outcomes during GLP-1 receptor agonist therapy, though protein intake targets and resistance training are not addressed in her account.
- The STEP 1 trial (Wilding et al., 2021, NEJM) showed average weight loss of ~14.9% of body weight on semaglutide 2.4mg, making a 22kg loss biologically plausible but highly individual.
- Semaglutide suppresses appetite via hypothalamic pathways and delayed gastric emptying, which explains why Sharon reports not feeling hungry enough to snack.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compounded Semaglutide decisions still need source quality, legal access, and provider oversight checks.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against the Compounded Semaglutide guide, cost path, safety notes, and provider review before acting.
Review Compounded SemaglutideWhat You'll Learn
- The STEP 1 trial (Wilding et al., 2021, NEJM) showed average weight loss of ~14.9% of body weight on semaglutide 2.4mg, making a 22kg loss biologically plausible but highly individual.
- Semaglutide suppresses appetite via hypothalamic pathways and delayed gastric emptying, which explains why Sharon reports not feeling hungry enough to snack.
- Research (Bikou et al., 2023, Nutrients) indicates that without deliberate protein prioritization, GLP-1-assisted weight loss can include significant lean muscle mass loss, not only fat.
- Current clinical guidance suggests aiming for at least 1.2g of protein per kilogram of body weight daily during GLP-1 therapy, ideally combined with resistance training.
- Reducing alcohol during semaglutide treatment is well-supported: it removes empty calories, supports insulin sensitivity, and may reduce gastrointestinal side effects.
- Collagen supplements are widely used but the evidence for benefits beyond those from standard whole-food protein sources remains limited and often industry-funded (Shaw et al., 2017, British Journal of Nutrition).
- A single-day food diary from one user at an unknown dose and stage of treatment is not a template. Anyone on or considering GLP-1 therapy should consult a prescribing clinician and a registered dietitian.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @sharonvanwyk3 actually say?
Sharon kept it refreshingly simple. She described a single day of eating on semaglutide (Ozempic) that she credits with a 22kg weight loss "so far." Breakfast was chia seeds soaked in Greek yogurt with collagen, low-carb granola, maple syrup, and blueberries. Lunch was an Asian slaw with rotisserie chicken. Dinner was spiced chicken off the braai with salad and a baked potato. She was clear that there is "no meal plan" and that she is "just following the basic principles of a balanced diet" with "no food exclusions" aside from cutting back significantly on alcohol. She also noted she generally does not snack because the medication blunts her hunger enough that she simply does not feel like eating more.
This is a personal account, not a prescription. She did not claim to be a dietitian, she did not push supplements aggressively, and she did not tell viewers to copy her plate. Credit where it is due: that framing is more responsible than most GLP-1 content on TikTok.
Does the science back this up?
Broadly, yes. The eating pattern she described, protein-forward, vegetable-heavy, moderate carbohydrate, reduced alcohol, no rigid exclusions, is consistent with what researchers recommend for people on GLP-1 receptor agonists. The weight loss figure of 22kg is plausible and sits within the range seen in clinical trials.
The STEP 1 trial (Wilding et al., 2021, New England Journal of Medicine) found that semaglutide 2.4mg weekly produced an average body weight reduction of about 14.9% over 68 weeks, which for many people translates to 15-20kg or more depending on starting weight. Sharon's 22kg loss is entirely within that range, though individual results vary considerably. The appetite suppression she describes, not feeling hungry enough to snack, is also well-documented. Semaglutide slows gastric emptying and acts on hypothalamic satiety pathways, which is why people on it often report eating substantially less without feeling deprived (Drucker, 2018, Cell Metabolism). Her protein and fiber choices would also help maintain muscle mass during caloric restriction, which is a legitimate concern on any significant weight loss program.
What did they get wrong (or right)?
She got the broad strokes right. The meal she described is genuinely balanced: Greek yogurt and chicken provide adequate protein, the vegetables in the slaw and salad supply fiber and micronutrients, and the baked potato is a reasonable whole-food carbohydrate source. The reduction in alcohol is also clinically sensible. Alcohol is calorie-dense, disrupts sleep and insulin sensitivity, and can interact poorly with nausea that some people experience on GLP-1 medications.
The collagen supplement is where things get a little wobbly. Collagen is popular, but the evidence that oral collagen supplementation meaningfully improves skin, joints, or body composition in otherwise healthy adults is thin and largely industry-funded (Shaw et al., 2017, British Journal of Nutrition). It is not harmful, but it is not the protein workhorse she might think it is. Dietary protein from whole foods like yogurt and chicken does the heavy lifting. The maple syrup addition is also worth a flag: it is a small amount and not a dealbreaker, but added sugars offer little nutritional value and can make blood sugar management harder, which matters more when you are on a medication that already affects gastric emptying.
What should you actually know?
Sharon's approach works for her, and the principles she is applying are sound. But a one-day food diary from one person on one dose of one medication tells you almost nothing about what you should eat. GLP-1 receptor agonists reduce appetite dramatically for most users, which means people can accidentally undereat protein and muscle loss becomes a real risk over months of use.
Research published by Bikou et al. (2023, Nutrients) and others has flagged that without deliberate protein prioritization, a meaningful portion of weight lost on semaglutide can come from lean mass, not just fat. The current clinical consensus leans toward at least 1.2g of protein per kilogram of body weight per day during GLP-1-assisted weight loss, combined with resistance training. Sharon's meals look protein-reasonable, but a single day of eating cannot confirm she is hitting that target consistently. Anyone starting or adjusting a GLP-1 medication should work with a registered dietitian and their prescribing clinician, not reverse-engineer a TikTok food diary.
- GLP-1 medications require a prescription and medical supervision. They are not appropriate for everyone.
- Individual weight loss results vary significantly based on dose, starting weight, diet quality, activity level, and adherence.
- Alcohol reduction on GLP-1 therapy is supported by both metabolic and tolerability evidence.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Sharon van Wyk 🇿🇦 · TikTok creator
63.9K views on this video
I thought I'd do a more "summary" edition of what I eat in a day on Ozempic that has resulted in my 22kg weight loss 𝑺𝑶 𝑭𝑨𝑹... Was this helpful? Let me know in the comments! #southafricatiktok🇿🇦 #southafricatiktok
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about the step 1 trial (wilding et al., 2021, nejm) showed?
The STEP 1 trial (Wilding et al., 2021, NEJM) showed average weight loss of ~14.9% of body weight on semaglutide 2.4mg, making a 22kg loss biologically plausible but highly individual.
What does the video say about semaglutide suppresses appetite via hypothalamic pathways?
Semaglutide suppresses appetite via hypothalamic pathways and delayed gastric emptying, which explains why Sharon reports not feeling hungry enough to snack.
What does the video say about research (bikou et al., 2023, nutrients) indicates?
Research (Bikou et al., 2023, Nutrients) indicates that without deliberate protein prioritization, GLP-1-assisted weight loss can include significant lean muscle mass loss, not only fat.
What does the video say about current clinical guidance suggests aiming for at least 1.2g of?
Current clinical guidance suggests aiming for at least 1.2g of protein per kilogram of body weight daily during GLP-1 therapy, ideally combined with resistance training.
What does the video say about reducing alcohol during semaglutide treatment?
Reducing alcohol during semaglutide treatment is well-supported: it removes empty calories, supports insulin sensitivity, and may reduce gastrointestinal side effects.
What does the video say about collagen supplements?
Collagen supplements are widely used but the evidence for benefits beyond those from standard whole-food protein sources remains limited and often industry-funded (Shaw et al., 2017, British Journal of Nutrition).
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Sharon van Wyk 🇿🇦, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.